Salesforce Cost-Cutting Efforts Lead to Upbeat Earnings, 12% Jump in Stock Price: Time to Buy?
Salesforce (CRM) delivered its 4th quarter earnings yesterday after trading hours, and the stock is up 12% so far in Thursday’s session. The company’s cost-cutting efforts are starting to pay off in a major way. Revenue itself soared 14% up to $8.38 billion, but what really has investors and analysts excited is profitability. The company saw a 100% growth [...]
Lowes Drops 5% From Earnings Miss & Lackluster Outlook: 3 Things For Investors to Take Note of
Early Wednesday, Lowes (LOW) reported its fiscal fourth-quarter earnings - which left much to be desired. The company missed revenue estimates and took a step back in profit. And to make matters worse, the company expects 2023 to be a step backward. While Wall Street was expecting revenue of $22.69 billion, Lowes came up just short at $22.45 billion. [...]
THE SEVEN DEADLY SINS OF INVESTING.
Dr. DiLiddo may be retired, but he’s not done sharing his wisdom. I don’t believe that he’ll ever retire from sharing his insights and expertise in an effort to help individual investors, like you and me, make money in the stock market. His most recent brainchild, The Seven Deadly Sins of Investing, is one that I have been chomping [...]
Talks of Leadership Change Send Union Pacific Shares Trading 10% Higher: Is it Worth a Buy?
Over the weekend, Union Pacific (UNP) announced that the current CEO Lance Fritz is on his way out, and a leadership change will come by the end of the year. While the railroad company just delivered an impressive Q4 profit, a hedge fund that controls a $1.6b stake in the company publicly lambasted Fritz and the direction the company [...]
Seagen Jumps 11% on Pfizer Acquisition Rumors – Should You Buy the Hype Early?
As Pfizer’s sales continue to struggle, they’ve turned to acquisitions as a means of making up for lost revenue. And one company they have their eye on is Seagen - a cancer drugmaker with a market cap of roughly $30 billion. Last year, Seagen was rumored to be acquired by Merck. This deal could have cost as much as [...]
Carvana Stock Has Lost 98% Of Its Value—Could CVNA Make a Comeback?
Carvana (CVNA) reported fourth-quarter and full-year 2022 results on Friday. Shares fell more than 21% after the announcement. In its annual report, the company registered a more profound deficit for 2022 and an overall decrease of 3% in vehicles sold to customers compared to 2021. Furthermore, the integration of Adesa's car auction business adversely impacted their 4th quarter and [...]
